# High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome

> **NCT00716300** · — · UNKNOWN · sponsor: **The University of Western Australia** · enrollment: 30 (estimated)

## Conditions studied

- Metabolic Syndrome X

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00716300
- **Lead sponsor:** The University of Western Australia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2009-06
- **Final completion:** 2009-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00716300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00716300, "High Density Lipoprotein (HDL) Functionality in Metabolic Syndrome". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00716300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*